Ozempic, a widely-used medication for managing type 2 diabetes, has been in short supply across Australia since early 2022. This shortage was largely driven by a sudden spike in demand, not only for its diabetes management properties but also due to its off-label use for weight loss. The manufacturer, Novo Nordisk, has been struggling to keep up with this global demand, leading to ongoing stock shortages in Australia.
Current Supply Situation
The Therapeutic Goods Administration (TGA) has indicated that the Ozempic shortage will likely continue throughout 2024. Although availability has improved slightly, the demand remains incredibly high, and the medication will be listed as being in shortage until the situation stabilises. The TGA and Novo Nordisk are working together to monitor the situation, but consistent supply may not be fully restored until late 2024.
To mitigate the issue, the TGA has temporarily approved the supply of overseas-registered semaglutide products. These alternatives are similar to Ozempic but come at a higher cost and are not subsidised under the Pharmaceutical Benefits Scheme (PBS), which makes them less accessible for some patients.
Why the Shortage?
Several factors have contributed to this ongoing shortage. A key reason is the off-label use of Ozempic for weight loss, which saw a huge surge in demand after social media platforms like TikTok popularised the drug for its weight management effects. This unanticipated demand put enormous pressure on the supply chain.
Another contributing factor is the complexity involved in manufacturing semaglutide, the active ingredient in Ozempic. The production process requires specialised facilities, making it difficult to ramp up production quickly to meet the increased demand.
Managing the Shortage
Patients who rely on Ozempic to manage their diabetes have faced significant challenges during this shortage. Pharmacies are being advised to prioritise those with type 2 diabetes, as this is the primary approved use of the medication. If you are one of those affected by the shortage, it’s important to consult with your healthcare provider to explore alternative medications in the meantime.
Some online platforms, such as Chemist2U, may have limited stocks available from time to time, but supplies are generally limited. It’s worth checking with your local pharmacy regularly, as small batches of Ozempic continue to arrive intermittently.
The Road Ahead
While Ozempic remains in short supply, there is hope that the situation will gradually improve over the course of 2024. Novo Nordisk is actively working with Australian healthcare bodies to address the shortage, but it will take time for production to meet the high demand. In the meantime, patients are encouraged to stay in close contact with their healthcare providers for updates and guidance.
For those affected by the shortage, regular updates on stock levels are available through healthcare providers and pharmacy networks. Keep an eye out for information and consult your doctor if you need to adjust your treatment plan during this period.